Enoxaparin Sodium Injection
Product Images NDC 0548-5605

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0548-5605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Stock No.: 5601 (principal Panel) (Carton 5601a)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL by Amphastar Pharmaceuticals, Inc. The label indicates a subcutaneous injection with 10 single dose syringes of 30 mg each, featuring an automatic safety device. The label includes Rx only designation and contact information for reporting adverse effects.*

FDA Label Image

Carton Stock No.: 5601 (Carton 5601b)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL, presented as 10 single-dose syringes. The label states the product is for subcutaneous injection, derived from porcine intestinal mucosa, and includes storage instructions at 25°C with permitted excursions. It is labeled for Rx only and manufactured by Amphastar Pharmaceuticals, Inc. The label also contains illustrated directions for subcutaneous administration.*

FDA Label Image

Carton Stock No.: 5602 (principal Display) (Carton 5602a)

Enoxaparin Sodium Injection 40 mg/0.4 mL subcutaneous injection packaging label. The label indicates Rx only and contains ten 40 mg single dose syringes with automatic safety devices. The labeler is Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA, USA. The label features a yellow and white color scheme.*

FDA Label Image

Carton Stock No.: 5602 (Carton 5602b)

Packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL by Amphastar Pharmaceuticals, Inc. The carton is for a single-use, prefilled syringe intended for subcutaneous injection. The label instructs that the product contains 10 syringes of 40 mg each and includes directions for use and storage instructions, emphasizing Rx only and child safety warnings.*

FDA Label Image

Carton Stock No.: 5603 (principal Panel) (Carton 5603a)

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL by Amphastar Pharmaceuticals, Inc. The label indicates the product is for subcutaneous injection and includes 10 x 60 mg single dose syringes with an automatic safety device. The label features an orange and white design with dosage and usage information.*

FDA Label Image

Carton Stock No.: 5603 (Carton 5603b)

Packaging label for Enoxaparin Sodium Injection, 60 mg per 0.6 mL, provided as 10 single dose syringes. The label specifies this is a non-varnish area and includes directions for subcutaneous injection use, warnings to keep out of reach of children, and storage instructions at 15-30°C (59-86°F). The product is labeled for prescription use only from Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Carton Stock No.: 5604 (principal Panel) (Carton 5604a)

Enoxaparin Sodium Injection 80 mg/0.8 mL carton label for subcutaneous use. The packaging indicates 10 single dose syringes with automatic safety devices. The label states Rx only and includes the Amphastar Pharmaceuticals, Inc. logo and address. The design features a brown and white color scheme with clear dosage and usage instructions.*

FDA Label Image

Carton Stock No.: 5604 (Carton 5604b)

Packaging label for Enoxaparin Sodium Injection, 80 mg/0.8 mL, supplied as 10 single dose syringes. The label states the product is for subcutaneous injection and includes directions for use illustrations. It warns to keep out of reach of children, recommends storage at 25°C with allowed excursions between 15-30°C, and notes it is Rx only. The labeler is Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Carton Stock No.: 5605 (principal Panel) (Carton 5605a)

Packaging label for Enoxaparin Sodium Injection 100 mg/mL by Amphastar Pharmaceuticals, Inc. Contains ten 1 mL single-dose syringes with automatic safety devices for subcutaneous injection. The label includes dosage strength, quantity, route of administration, and manufacturer information.*

FDA Label Image

Carton Stock No.: 5605 (Carton 5605b)

Packaging label for Enoxaparin Sodium Injection 100 mg/mL by Amphastar Pharmaceuticals, Inc. The label is for single-dose syringes with a pack size of 10 syringes. It includes directions for use, dosing information, and storage instructions, emphasizing subcutaneous administration and refrigeration between 15-30°C. The label also contains warnings and disposal guidance.*

FDA Label Image

Carton Stock No.: 5606 (principal Panel) (Carton 5606a)

The packaging label for Enoxaparin Sodium Injection by Amphastar Pharmaceuticals, Inc. shows a dosage strength of 120 mg/0.8 mL for subcutaneous injection. The carton contains 10 single-dose syringes with an automatic safety device. Packaging includes contact information and required regulatory text.*

FDA Label Image

Carton Stock No.: 5606 (Carton 5606b)

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL by Amphastar Pharmaceuticals, Inc. The label indicates 10 single-dose syringes, each containing 120 mg of enoxaparin sodium in 0.8 mL for subcutaneous injection. It includes usage directions and storage instructions, emphasizing controlled room temperature storage and warning to keep out of reach of children.*

FDA Label Image

Carton Stock No.: 5607 (principal Panel) (Carton 5607a)

Packaging label for Enoxaparin Sodium Injection 150 mg/mL in 1 mL syringes by Amphastar Pharmaceuticals, Inc. The carton contains 10 single-dose syringes with an automatic safety device. The product is for subcutaneous injection and is labeled Rx only. The label includes manufacturer information and prescribing details.*

FDA Label Image

Carton Stock No.: 5607 (Carton 5607b)

Enoxaparin Sodium Injection label for subcutaneous use, 150 mg/mL strength in single-dose syringes. The label indicates 10 syringes per package, with detailed directions for use and warnings about storage and handling by Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Carton Stock No.: 5608 (principal Panel) (Carton 5608)

Packaging label for Enoxaparin Sodium Injection, USP 300 mg/3 mL (100 mg/mL) by Amphastar Pharmaceuticals, Inc. The label indicates it is a prescription injection for subcutaneous or intravenous use, provided as a multiple dose vial containing 3 mL. Storage instructions and warnings are included on the panel.*

FDA Label Image

Instructions 1 (Enoxaparin 00)

Illustration showing proper and improper handling of a prefilled syringe containing Enoxaparin Sodium injection. The left panel demonstrates correct use with a hand holding the syringe properly, while the right panel indicates an incorrect method with a crossed-out symbol over the image.*

FDA Label Image

Instructions 2 (Enoxaparin 01)

Illustration showing hands handling a syringe filled with a liquid medication, indicating a step in preparing or administering an injection with directional arrows pointing left and right along the syringe barrel.*

FDA Label Image

Instructions 3 (Enoxaparin 02)

An instructional diagram showing a hand holding a syringe with labeled components including a safety device and activation prongs. The image emphasizes not touching the safety device activation prongs, likely illustrating part of the correct handling or administration procedure for an injection product.*

FDA Label Image

Instructions 4 (Enoxaparin 03)

An instructional illustration depicting a close-up of hands preparing a syringe for injection, showing the process of removing or handling the syringe cap or needle cover. No additional text or labeling is visible.*

FDA Label Image

Instructions 5 (Enoxaparin 04)

An instructional illustration showing a hand holding a syringe, preparing to administer a subcutaneous injection. The image emphasizes the correct angle and technique for injection, relevant to the use of Enoxaparin Sodium injection by Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Instructions 6 (Enoxaparin 05)

An instructional diagram showing a hand holding a syringe and a vial in a preparation or injection process, likely related to the administration of Enoxaparin sodium injection. The image demonstrates proper handling technique for subcutaneous injection.*

FDA Label Image

Chemical Structure (Enoxaparin 06)

Chemical structure of Enoxaparin sodium, showing its polysaccharide chain with repeating units including sodium carboxylate groups, hydroxyl groups, and amino substituents.*

FDA Label Image

Chemical Structure (Enoxaparin 07)

Chemical structure of enoxaparin sodium, showing the molecular connectivity and arrangement of atoms specific to the active ingredient.*

FDA Label Image

Figure 1 (Enoxaparin 08)

A forest plot chart depicting relative risk comparisons between Unfractionated Heparin (UFH) and Enoxaparin (Enox) across multiple patient subgroups. The x-axis represents relative risk with markers showing Enoxaparin's effect better on the left and UFH better on the right. Patient subgroups include sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent use, time to treatment, and PCI status within 30 days. Data columns include number of patients, UFH percentage, Enox percentage, and risk reduction percentages.*

FDA Label Image

Figure 2 (Enoxaparin 09)

A Kaplan-Meier survival curve chart comparing the hazard of death or myocardial re-infarction over 30 days between Enoxaparin and UFH (unfractionated heparin). The chart includes data series labeled 'Enoxaparin' and 'UFH' with corresponding hazard rates on the vertical axis and time in days on the horizontal axis. The chart also contains an inset showing a similar comparison over a 1-year period, along with log-rank test p-values indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.